世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

人工臓器とバイオニックインプラントの世界市場成長(現状と展望)2022-2028年


Global Artificial Organs and Bionic Implants Market Growth (Status and Outlook) 2022-2028

世界経済の回復に伴い、人工臓器とバイオニックインプラントの2021年の成長も前年から大きく変化すると思われます。当社(LP Information)の最新調査によると、人工臓器とバイオニックインプラントの世界市場規... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2022年4月20日 US$3,660
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
123 英語

 

サマリー

世界経済の回復に伴い、人工臓器とバイオニックインプラントの2021年の成長も前年から大きく変化すると思われます。当社(LP Information)の最新調査によると、人工臓器とバイオニックインプラントの世界市場規模は2021年の8944.1百万米ドルから2022年には百万米ドルとなり、2021年から2022年の間に%変化します。世界の人工臓器とバイオニックインプラントの市場規模は、2028年には15000百万米ドルに達し、分析期間2022-2028年には7.7%のCAGRで成長すると予測されます。
米国の人工臓器およびバイオニックインプラント市場は、2021年に百万米ドルの価値があり、予測期間2022-2028年に約%のCAGRで成長すると予想されます。中国は、世界の人工臓器およびバイオニックインプラント市場の % 市場を構成し、2028 年までに 100 万米ドルに達します。ヨーロッパの人工臓器およびバイオニックインプラントの状況としては、ドイツは2028年までに100万米ドルに達すると予測され、予測期間2022-2028年のCAGRは%となっています。APACでは、他の注目すべき市場(日本、韓国)の成長率は、今後6年間、それぞれ%と%と予測されています。
世界の主な人工臓器・バイオニックインプラントプレイヤーは、Fresenius Medical Care、Cochlear、Abiomed、ABBOTTなどです。収益面では、世界の上位2社が2021年にほぼ%のシェアを占めています。
本レポートでは、人工臓器およびバイオニックインプラント市場の製品タイプ、アプリケーション、主要プレイヤー、主要地域、国別の包括的な概要、市場シェア、成長機会を紹介しています。
タイプ別区分:2.3項では2017年から2022年までの内訳データ、10.7項では2028年までの予測データを掲載しています。
人工腎臓
人工心臓、人工心肺補助装置
人工内耳
人工肺
人工肝臓
人工膵臓
義手・義足
その他
用途別セグメント:2017年から2022年までの内訳データは2.4節、2028年までの予測は10.8節に記載
商品化
臨床研究
また、本レポートでは、地域別に市場を分割しています。第4章、第5章、第6章、第7章、第8章における内訳データ。
米州
米国
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
本レポートでは、市場の競争環境とそれに対応する主要企業の詳細な分析も行っています。本レポートで取り上げている主要なプレイヤー第3章における内訳データ
フレゼニウス・メディカル・ケア
コクレア
アビオメッド
ABBOTT
バクスター
ビー・ブラウン
旭化成株式会社
ニプロ
メドエル
東レ・メディカル
ソノバ
メドトロニック
ゲティンゲ(マケ)
ウィリアム・デマント
リヴァノヴァ(ソリン)
テルモ
杭州ニュートロン
シンカルディア
コーウェーブ
リステント・メディカル
エバハート
オープンバイオニクス
OYMotionテクノロジーズ
メビウス・バイオニクス


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Organs and Bionic Implants Market Size 2017-2028
2.1.2 Artificial Organs and Bionic Implants Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artificial Organs and Bionic Implants Segment by Type
2.2.1 Artificial Kidney
2.2.2 Artificial Heart & Ventricular Assist Device
2.2.3 Cochlear Implant
2.2.4 Artificial Lung
2.2.5 Artificial Liver
2.2.6 Artificial Pancreas
2.2.7 Bionic Hands & Prosthetics
2.2.8 Others
2.3 Artificial Organs and Bionic Implants Market Size by Type
2.3.1 Artificial Organs and Bionic Implants Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artificial Organs and Bionic Implants Market Size Market Share by Type (2017-2022)
2.4 Artificial Organs and Bionic Implants Segment by Application
2.4.1 Commercialize
2.4.2 Clinical Research
2.5 Artificial Organs and Bionic Implants Market Size by Application
2.5.1 Artificial Organs and Bionic Implants Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artificial Organs and Bionic Implants Market Size Market Share by Application (2017-2022)
3 Artificial Organs and Bionic Implants Market Size by Player
3.1 Artificial Organs and Bionic Implants Market Size Market Share by Players
3.1.1 Global Artificial Organs and Bionic Implants Revenue by Players (2020-2022)
3.1.2 Global Artificial Organs and Bionic Implants Revenue Market Share by Players (2020-2022)
3.2 Global Artificial Organs and Bionic Implants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Organs and Bionic Implants by Regions
4.1 Artificial Organs and Bionic Implants Market Size by Regions (2017-2022)
4.2 Americas Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.3 APAC Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.4 Europe Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.5 Middle East & Africa Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artificial Organs and Bionic Implants Market Size by Country (2017-2022)
5.2 Americas Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
5.3 Americas Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Organs and Bionic Implants Market Size by Region (2017-2022)
6.2 APAC Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
6.3 APAC Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Organs and Bionic Implants by Country (2017-2022)
7.2 Europe Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
7.3 Europe Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Organs and Bionic Implants by Region (2017-2022)
8.2 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
8.3 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Organs and Bionic Implants Market Forecast
10.1 Global Artificial Organs and Bionic Implants Forecast by Regions (2023-2028)
10.1.1 Global Artificial Organs and Bionic Implants Forecast by Regions (2023-2028)
10.1.2 Americas Artificial Organs and Bionic Implants Forecast
10.1.3 APAC Artificial Organs and Bionic Implants Forecast
10.1.4 Europe Artificial Organs and Bionic Implants Forecast
10.1.5 Middle East & Africa Artificial Organs and Bionic Implants Forecast
10.2 Americas Artificial Organs and Bionic Implants Forecast by Country (2023-2028)
10.2.1 United States Artificial Organs and Bionic Implants Market Forecast
10.2.2 Canada Artificial Organs and Bionic Implants Market Forecast
10.2.3 Mexico Artificial Organs and Bionic Implants Market Forecast
10.2.4 Brazil Artificial Organs and Bionic Implants Market Forecast
10.3 APAC Artificial Organs and Bionic Implants Forecast by Region (2023-2028)
10.3.1 China Artificial Organs and Bionic Implants Market Forecast
10.3.2 Japan Artificial Organs and Bionic Implants Market Forecast
10.3.3 Korea Artificial Organs and Bionic Implants Market Forecast
10.3.4 Southeast Asia Artificial Organs and Bionic Implants Market Forecast
10.3.5 India Artificial Organs and Bionic Implants Market Forecast
10.3.6 Australia Artificial Organs and Bionic Implants Market Forecast
10.4 Europe Artificial Organs and Bionic Implants Forecast by Country (2023-2028)
10.4.1 Germany Artificial Organs and Bionic Implants Market Forecast
10.4.2 France Artificial Organs and Bionic Implants Market Forecast
10.4.3 UK Artificial Organs and Bionic Implants Market Forecast
10.4.4 Italy Artificial Organs and Bionic Implants Market Forecast
10.4.5 Russia Artificial Organs and Bionic Implants Market Forecast
10.5 Middle East & Africa Artificial Organs and Bionic Implants Forecast by Region (2023-2028)
10.5.1 Egypt Artificial Organs and Bionic Implants Market Forecast
10.5.2 South Africa Artificial Organs and Bionic Implants Market Forecast
10.5.3 Israel Artificial Organs and Bionic Implants Market Forecast
10.5.4 Turkey Artificial Organs and Bionic Implants Market Forecast
10.5.5 GCC Countries Artificial Organs and Bionic Implants Market Forecast
10.6 Global Artificial Organs and Bionic Implants Forecast by Type (2023-2028)
10.7 Global Artificial Organs and Bionic Implants Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Information
11.1.2 Fresenius Medical Care Artificial Organs and Bionic Implants Product Offered
11.1.3 Fresenius Medical Care Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fresenius Medical Care Main Business Overview
11.1.5 Fresenius Medical Care Latest Developments
11.2 Cochlear
11.2.1 Cochlear Company Information
11.2.2 Cochlear Artificial Organs and Bionic Implants Product Offered
11.2.3 Cochlear Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cochlear Main Business Overview
11.2.5 Cochlear Latest Developments
11.3 Abiomed
11.3.1 Abiomed Company Information
11.3.2 Abiomed Artificial Organs and Bionic Implants Product Offered
11.3.3 Abiomed Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abiomed Main Business Overview
11.3.5 Abiomed Latest Developments
11.4 ABBOTT
11.4.1 ABBOTT Company Information
11.4.2 ABBOTT Artificial Organs and Bionic Implants Product Offered
11.4.3 ABBOTT Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ABBOTT Main Business Overview
11.4.5 ABBOTT Latest Developments
11.5 Baxter
11.5.1 Baxter Company Information
11.5.2 Baxter Artificial Organs and Bionic Implants Product Offered
11.5.3 Baxter Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Baxter Main Business Overview
11.5.5 Baxter Latest Developments
11.6 B.Braun
11.6.1 B.Braun Company Information
11.6.2 B.Braun Artificial Organs and Bionic Implants Product Offered
11.6.3 B.Braun Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 B.Braun Main Business Overview
11.6.5 B.Braun Latest Developments
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Information
11.7.2 Asahi Kasei Corporation Artificial Organs and Bionic Implants Product Offered
11.7.3 Asahi Kasei Corporation Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Asahi Kasei Corporation Main Business Overview
11.7.5 Asahi Kasei Corporation Latest Developments
11.8 Nipro
11.8.1 Nipro Company Information
11.8.2 Nipro Artificial Organs and Bionic Implants Product Offered
11.8.3 Nipro Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Nipro Main Business Overview
11.8.5 Nipro Latest Developments
11.9 MED-EL
11.9.1 MED-EL Company Information
11.9.2 MED-EL Artificial Organs and Bionic Implants Product Offered
11.9.3 MED-EL Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 MED-EL Main Business Overview
11.9.5 MED-EL Latest Developments
11.10 Toray Medical
11.10.1 Toray Medical Company Information
11.10.2 Toray Medical Artificial Organs and Bionic Implants Product Offered
11.10.3 Toray Medical Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Toray Medical Main Business Overview
11.10.5 Toray Medical Latest Developments
11.11 Sonova
11.11.1 Sonova Company Information
11.11.2 Sonova Artificial Organs and Bionic Implants Product Offered
11.11.3 Sonova Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sonova Main Business Overview
11.11.5 Sonova Latest Developments
11.12 Medtronic
11.12.1 Medtronic Company Information
11.12.2 Medtronic Artificial Organs and Bionic Implants Product Offered
11.12.3 Medtronic Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Medtronic Main Business Overview
11.12.5 Medtronic Latest Developments
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Information
11.13.2 Getinge (Maquet) Artificial Organs and Bionic Implants Product Offered
11.13.3 Getinge (Maquet) Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Getinge (Maquet) Main Business Overview
11.13.5 Getinge (Maquet) Latest Developments
11.14 William Demant
11.14.1 William Demant Company Information
11.14.2 William Demant Artificial Organs and Bionic Implants Product Offered
11.14.3 William Demant Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 William Demant Main Business Overview
11.14.5 William Demant Latest Developments
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Information
11.15.2 LivaNova (Sorin) Artificial Organs and Bionic Implants Product Offered
11.15.3 LivaNova (Sorin) Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 LivaNova (Sorin) Main Business Overview
11.15.5 LivaNova (Sorin) Latest Developments
11.16 Terumo
11.16.1 Terumo Company Information
11.16.2 Terumo Artificial Organs and Bionic Implants Product Offered
11.16.3 Terumo Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Terumo Main Business Overview
11.16.5 Terumo Latest Developments
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Information
11.17.2 Hangzhou Nurotron Artificial Organs and Bionic Implants Product Offered
11.17.3 Hangzhou Nurotron Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Hangzhou Nurotron Main Business Overview
11.17.5 Hangzhou Nurotron Latest Developments
11.18 Syncardia
11.18.1 Syncardia Company Information
11.18.2 Syncardia Artificial Organs and Bionic Implants Product Offered
11.18.3 Syncardia Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Syncardia Main Business Overview
11.18.5 Syncardia Latest Developments
11.19 CorWave
11.19.1 CorWave Company Information
11.19.2 CorWave Artificial Organs and Bionic Implants Product Offered
11.19.3 CorWave Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 CorWave Main Business Overview
11.19.5 CorWave Latest Developments
11.20 Listent Medical
11.20.1 Listent Medical Company Information
11.20.2 Listent Medical Artificial Organs and Bionic Implants Product Offered
11.20.3 Listent Medical Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Listent Medical Main Business Overview
11.20.5 Listent Medical Latest Developments
11.21 Evaheart
11.21.1 Evaheart Company Information
11.21.2 Evaheart Artificial Organs and Bionic Implants Product Offered
11.21.3 Evaheart Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Evaheart Main Business Overview
11.21.5 Evaheart Latest Developments
11.22 Open Bionics
11.22.1 Open Bionics Company Information
11.22.2 Open Bionics Artificial Organs and Bionic Implants Product Offered
11.22.3 Open Bionics Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Open Bionics Main Business Overview
11.22.5 Open Bionics Latest Developments
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Information
11.23.2 OYMotion Technologies Artificial Organs and Bionic Implants Product Offered
11.23.3 OYMotion Technologies Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 OYMotion Technologies Main Business Overview
11.23.5 OYMotion Technologies Latest Developments
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Information
11.24.2 Mobius Bionics Artificial Organs and Bionic Implants Product Offered
11.24.3 Mobius Bionics Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Mobius Bionics Main Business Overview
11.24.5 Mobius Bionics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

As the global economy mends, the 2021 growth of Artificial Organs and Bionic Implants will have significant change from previous year. According to our (LP Information) latest study, the global Artificial Organs and Bionic Implants market size is USD million in 2022 from USD 8944.1 million in 2021, with a change of % between 2021 and 2022. The global Artificial Organs and Bionic Implants market size will reach USD 15000 million in 2028, growing at a CAGR of 7.7% over the analysis period 2022-2028.
The United States Artificial Organs and Bionic Implants market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Artificial Organs and Bionic Implants market, reaching US$ million by the year 2028. As for the Europe Artificial Organs and Bionic Implants landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Artificial Organs and Bionic Implants players cover Fresenius Medical Care, Cochlear, Abiomed, and ABBOTT, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Organs and Bionic Implants market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Commercialize
Clinical Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Organs and Bionic Implants Market Size 2017-2028
2.1.2 Artificial Organs and Bionic Implants Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artificial Organs and Bionic Implants Segment by Type
2.2.1 Artificial Kidney
2.2.2 Artificial Heart & Ventricular Assist Device
2.2.3 Cochlear Implant
2.2.4 Artificial Lung
2.2.5 Artificial Liver
2.2.6 Artificial Pancreas
2.2.7 Bionic Hands & Prosthetics
2.2.8 Others
2.3 Artificial Organs and Bionic Implants Market Size by Type
2.3.1 Artificial Organs and Bionic Implants Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artificial Organs and Bionic Implants Market Size Market Share by Type (2017-2022)
2.4 Artificial Organs and Bionic Implants Segment by Application
2.4.1 Commercialize
2.4.2 Clinical Research
2.5 Artificial Organs and Bionic Implants Market Size by Application
2.5.1 Artificial Organs and Bionic Implants Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artificial Organs and Bionic Implants Market Size Market Share by Application (2017-2022)
3 Artificial Organs and Bionic Implants Market Size by Player
3.1 Artificial Organs and Bionic Implants Market Size Market Share by Players
3.1.1 Global Artificial Organs and Bionic Implants Revenue by Players (2020-2022)
3.1.2 Global Artificial Organs and Bionic Implants Revenue Market Share by Players (2020-2022)
3.2 Global Artificial Organs and Bionic Implants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Organs and Bionic Implants by Regions
4.1 Artificial Organs and Bionic Implants Market Size by Regions (2017-2022)
4.2 Americas Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.3 APAC Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.4 Europe Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
4.5 Middle East & Africa Artificial Organs and Bionic Implants Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artificial Organs and Bionic Implants Market Size by Country (2017-2022)
5.2 Americas Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
5.3 Americas Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Organs and Bionic Implants Market Size by Region (2017-2022)
6.2 APAC Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
6.3 APAC Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Organs and Bionic Implants by Country (2017-2022)
7.2 Europe Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
7.3 Europe Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Organs and Bionic Implants by Region (2017-2022)
8.2 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Type (2017-2022)
8.3 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Organs and Bionic Implants Market Forecast
10.1 Global Artificial Organs and Bionic Implants Forecast by Regions (2023-2028)
10.1.1 Global Artificial Organs and Bionic Implants Forecast by Regions (2023-2028)
10.1.2 Americas Artificial Organs and Bionic Implants Forecast
10.1.3 APAC Artificial Organs and Bionic Implants Forecast
10.1.4 Europe Artificial Organs and Bionic Implants Forecast
10.1.5 Middle East & Africa Artificial Organs and Bionic Implants Forecast
10.2 Americas Artificial Organs and Bionic Implants Forecast by Country (2023-2028)
10.2.1 United States Artificial Organs and Bionic Implants Market Forecast
10.2.2 Canada Artificial Organs and Bionic Implants Market Forecast
10.2.3 Mexico Artificial Organs and Bionic Implants Market Forecast
10.2.4 Brazil Artificial Organs and Bionic Implants Market Forecast
10.3 APAC Artificial Organs and Bionic Implants Forecast by Region (2023-2028)
10.3.1 China Artificial Organs and Bionic Implants Market Forecast
10.3.2 Japan Artificial Organs and Bionic Implants Market Forecast
10.3.3 Korea Artificial Organs and Bionic Implants Market Forecast
10.3.4 Southeast Asia Artificial Organs and Bionic Implants Market Forecast
10.3.5 India Artificial Organs and Bionic Implants Market Forecast
10.3.6 Australia Artificial Organs and Bionic Implants Market Forecast
10.4 Europe Artificial Organs and Bionic Implants Forecast by Country (2023-2028)
10.4.1 Germany Artificial Organs and Bionic Implants Market Forecast
10.4.2 France Artificial Organs and Bionic Implants Market Forecast
10.4.3 UK Artificial Organs and Bionic Implants Market Forecast
10.4.4 Italy Artificial Organs and Bionic Implants Market Forecast
10.4.5 Russia Artificial Organs and Bionic Implants Market Forecast
10.5 Middle East & Africa Artificial Organs and Bionic Implants Forecast by Region (2023-2028)
10.5.1 Egypt Artificial Organs and Bionic Implants Market Forecast
10.5.2 South Africa Artificial Organs and Bionic Implants Market Forecast
10.5.3 Israel Artificial Organs and Bionic Implants Market Forecast
10.5.4 Turkey Artificial Organs and Bionic Implants Market Forecast
10.5.5 GCC Countries Artificial Organs and Bionic Implants Market Forecast
10.6 Global Artificial Organs and Bionic Implants Forecast by Type (2023-2028)
10.7 Global Artificial Organs and Bionic Implants Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Information
11.1.2 Fresenius Medical Care Artificial Organs and Bionic Implants Product Offered
11.1.3 Fresenius Medical Care Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fresenius Medical Care Main Business Overview
11.1.5 Fresenius Medical Care Latest Developments
11.2 Cochlear
11.2.1 Cochlear Company Information
11.2.2 Cochlear Artificial Organs and Bionic Implants Product Offered
11.2.3 Cochlear Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Cochlear Main Business Overview
11.2.5 Cochlear Latest Developments
11.3 Abiomed
11.3.1 Abiomed Company Information
11.3.2 Abiomed Artificial Organs and Bionic Implants Product Offered
11.3.3 Abiomed Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abiomed Main Business Overview
11.3.5 Abiomed Latest Developments
11.4 ABBOTT
11.4.1 ABBOTT Company Information
11.4.2 ABBOTT Artificial Organs and Bionic Implants Product Offered
11.4.3 ABBOTT Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 ABBOTT Main Business Overview
11.4.5 ABBOTT Latest Developments
11.5 Baxter
11.5.1 Baxter Company Information
11.5.2 Baxter Artificial Organs and Bionic Implants Product Offered
11.5.3 Baxter Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Baxter Main Business Overview
11.5.5 Baxter Latest Developments
11.6 B.Braun
11.6.1 B.Braun Company Information
11.6.2 B.Braun Artificial Organs and Bionic Implants Product Offered
11.6.3 B.Braun Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 B.Braun Main Business Overview
11.6.5 B.Braun Latest Developments
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Information
11.7.2 Asahi Kasei Corporation Artificial Organs and Bionic Implants Product Offered
11.7.3 Asahi Kasei Corporation Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Asahi Kasei Corporation Main Business Overview
11.7.5 Asahi Kasei Corporation Latest Developments
11.8 Nipro
11.8.1 Nipro Company Information
11.8.2 Nipro Artificial Organs and Bionic Implants Product Offered
11.8.3 Nipro Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Nipro Main Business Overview
11.8.5 Nipro Latest Developments
11.9 MED-EL
11.9.1 MED-EL Company Information
11.9.2 MED-EL Artificial Organs and Bionic Implants Product Offered
11.9.3 MED-EL Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 MED-EL Main Business Overview
11.9.5 MED-EL Latest Developments
11.10 Toray Medical
11.10.1 Toray Medical Company Information
11.10.2 Toray Medical Artificial Organs and Bionic Implants Product Offered
11.10.3 Toray Medical Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Toray Medical Main Business Overview
11.10.5 Toray Medical Latest Developments
11.11 Sonova
11.11.1 Sonova Company Information
11.11.2 Sonova Artificial Organs and Bionic Implants Product Offered
11.11.3 Sonova Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sonova Main Business Overview
11.11.5 Sonova Latest Developments
11.12 Medtronic
11.12.1 Medtronic Company Information
11.12.2 Medtronic Artificial Organs and Bionic Implants Product Offered
11.12.3 Medtronic Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Medtronic Main Business Overview
11.12.5 Medtronic Latest Developments
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Information
11.13.2 Getinge (Maquet) Artificial Organs and Bionic Implants Product Offered
11.13.3 Getinge (Maquet) Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Getinge (Maquet) Main Business Overview
11.13.5 Getinge (Maquet) Latest Developments
11.14 William Demant
11.14.1 William Demant Company Information
11.14.2 William Demant Artificial Organs and Bionic Implants Product Offered
11.14.3 William Demant Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 William Demant Main Business Overview
11.14.5 William Demant Latest Developments
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Information
11.15.2 LivaNova (Sorin) Artificial Organs and Bionic Implants Product Offered
11.15.3 LivaNova (Sorin) Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 LivaNova (Sorin) Main Business Overview
11.15.5 LivaNova (Sorin) Latest Developments
11.16 Terumo
11.16.1 Terumo Company Information
11.16.2 Terumo Artificial Organs and Bionic Implants Product Offered
11.16.3 Terumo Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Terumo Main Business Overview
11.16.5 Terumo Latest Developments
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Information
11.17.2 Hangzhou Nurotron Artificial Organs and Bionic Implants Product Offered
11.17.3 Hangzhou Nurotron Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Hangzhou Nurotron Main Business Overview
11.17.5 Hangzhou Nurotron Latest Developments
11.18 Syncardia
11.18.1 Syncardia Company Information
11.18.2 Syncardia Artificial Organs and Bionic Implants Product Offered
11.18.3 Syncardia Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Syncardia Main Business Overview
11.18.5 Syncardia Latest Developments
11.19 CorWave
11.19.1 CorWave Company Information
11.19.2 CorWave Artificial Organs and Bionic Implants Product Offered
11.19.3 CorWave Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 CorWave Main Business Overview
11.19.5 CorWave Latest Developments
11.20 Listent Medical
11.20.1 Listent Medical Company Information
11.20.2 Listent Medical Artificial Organs and Bionic Implants Product Offered
11.20.3 Listent Medical Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Listent Medical Main Business Overview
11.20.5 Listent Medical Latest Developments
11.21 Evaheart
11.21.1 Evaheart Company Information
11.21.2 Evaheart Artificial Organs and Bionic Implants Product Offered
11.21.3 Evaheart Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Evaheart Main Business Overview
11.21.5 Evaheart Latest Developments
11.22 Open Bionics
11.22.1 Open Bionics Company Information
11.22.2 Open Bionics Artificial Organs and Bionic Implants Product Offered
11.22.3 Open Bionics Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Open Bionics Main Business Overview
11.22.5 Open Bionics Latest Developments
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Information
11.23.2 OYMotion Technologies Artificial Organs and Bionic Implants Product Offered
11.23.3 OYMotion Technologies Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 OYMotion Technologies Main Business Overview
11.23.5 OYMotion Technologies Latest Developments
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Information
11.24.2 Mobius Bionics Artificial Organs and Bionic Implants Product Offered
11.24.3 Mobius Bionics Artificial Organs and Bionic Implants Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Mobius Bionics Main Business Overview
11.24.5 Mobius Bionics Latest Developments
12 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る